KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Net Income towards Common Stockholders (2016 - 2025)

Chemed (CHE) has 17 years of Net Income towards Common Stockholders data on record, last reported at $76.8 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 59.02% year-over-year to $76.8 million; the TTM value through Dec 2025 reached $265.2 million, down 33.52%, while the annual FY2025 figure was $265.2 million, 33.52% down from the prior year.
  • Net Income towards Common Stockholders reached $76.8 million in Q4 2025 per CHE's latest filing, up from $64.2 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $187.3 million in Q4 2024 and bottomed at $52.5 million in Q2 2025.
  • Average Net Income towards Common Stockholders over 5 years is $83.6 million, with a median of $68.7 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 32.8% in 2024, then plummeted 59.02% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $155.9 million in 2021, then decreased by 16.37% to $130.4 million in 2022, then grew by 21.14% to $157.9 million in 2023, then grew by 18.59% to $187.3 million in 2024, then tumbled by 59.02% to $76.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $76.8 million in Q4 2025, $64.2 million in Q3 2025, and $52.5 million in Q2 2025.